Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedAug 25, 2025
DataAggregated Company Financials
Companies15
  • 7D2.0%
  • 3M7.4%
  • 1Y-7.7%
  • YTD9.1%

Over the last 7 days, the Pharma industry has risen 2.0%, driven by gains from AstraZeneca of 2.0%. In contrast, the industry has lost 7.7% in the last 12 months. As for the next few years, earnings are expected to grow by 13% per annum.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 25 Aug 2025UK£284.3bUK£87.4bUK£11.7b21.3x24.3x3.3x
Wed, 23 Jul 2025UK£253.9bUK£86.3bUK£10.6b28.5x23.9x2.9x
Fri, 20 Jun 2025UK£262.9bUK£86.5bUK£10.6b26.1x24.7x3x
Sun, 18 May 2025UK£259.8bUK£87.2bUK£10.7b26.3x24.2x3x
Tue, 15 Apr 2025UK£254.6bUK£86.8bUK£9.6b30x26.5x2.9x
Thu, 13 Mar 2025UK£284.3bUK£87.6bUK£9.6b28.8x29.7x3.2x
Sat, 08 Feb 2025UK£280.9bUK£89.6bUK£9.6b30.1x29.4x3.1x
Mon, 06 Jan 2025UK£226.4bUK£75.8bUK£7.8b31.4x28.9x3x
Wed, 04 Dec 2024UK£230.7bUK£75.0bUK£7.7b31.1x29.8x3.1x
Fri, 01 Nov 2024UK£238.7bUK£72.6bUK£7.6b30.5x31.5x3.3x
Sun, 29 Sep 2024UK£250.9bUK£71.3bUK£8.9b30.5x28.1x3.5x
Tue, 27 Aug 2024UK£275.7bUK£71.8bUK£8.9b41.5x30.8x3.8x
Thu, 25 Jul 2024UK£258.6bUK£70.9bUK£9.5b35.5x27.3x3.6x
Sat, 22 Jun 2024UK£266.4bUK£71.7bUK£9.6b30.2x27.8x3.7x
Mon, 20 May 2024UK£268.2bUK£71.5bUK£9.6b34.9x28x3.7x
Wed, 17 Apr 2024UK£247.5bUK£71.4bUK£9.8b33x25.3x3.5x
Fri, 15 Mar 2024UK£239.1bUK£70.4bUK£9.7b31.4x24.6x3.4x
Sun, 11 Feb 2024UK£225.8bUK£69.7bUK£9.6b34.8x23.5x3.2x
Tue, 09 Jan 2024UK£241.6bUK£68.7bUK£10.7b36.1x22.7x3.5x
Thu, 07 Dec 2023UK£227.3bUK£69.3bUK£10.7b34.4x21.2x3.3x
Sat, 04 Nov 2023UK£229.8bUK£70.3bUK£11.0b53x20.9x3.3x
Mon, 02 Oct 2023UK£247.2bUK£70.5bUK£10.4b76.3x23.8x3.5x
Wed, 30 Aug 2023UK£238.7bUK£69.3bUK£10.2b53.5x23.4x3.4x
Fri, 28 Jul 2023UK£236.3bUK£67.6bUK£8.8b52x27x3.5x
Sun, 25 Jun 2023UK£248.0bUK£67.7bUK£7.9b55.5x31.5x3.7x
Tue, 23 May 2023UK£257.1bUK£68.6bUK£8.0b55.7x32.2x3.7x
Thu, 20 Apr 2023UK£259.5bUK£69.2bUK£6.9b57.2x37.8x3.7x
Sat, 18 Mar 2023UK£235.7bUK£70.1bUK£6.9b44.3x34x3.4x
Mon, 13 Feb 2023UK£249.4bUK£70.4bUK£7.4b40.8x33.8x3.5x
Wed, 11 Jan 2023UK£253.2bUK£79.8bUK£6.3b37.9x40x3.2x
Fri, 09 Dec 2022UK£247.5bUK£79.6bUK£6.3b35.9x39.2x3.1x
Sun, 06 Nov 2022UK£235.4bUK£80.7bUK£3.7b20.1x64.1x2.9x
Tue, 04 Oct 2022UK£215.9bUK£80.6bUK£3.7b20x58.9x2.7x
Thu, 01 Sep 2022UK£232.9bUK£79.4bUK£3.7b13.8x62.5x2.9x
Price to Earnings Ratio

62.5x


Total Market Cap: UK£232.9bTotal Earnings: UK£3.7bTotal Revenue: UK£79.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 32.1x202320242025
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 24.3x which is lower than its 3-year average PE of 32.1x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 46% per year over the last three years.
  • Revenues for these companies have grown 3.3% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market0.73%
Healthcare2.08%
Pharma2.02%
Pharma2.02%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£119.682.0%
+UK£3.6b
-8.5%PE30.2x
GSK GSKUK£14.802.8%
+UK£1.6b
-7.7%PE17.4x
HLN HaleonUK£3.651.1%
+UK£349.3m
-1.8%PE21.5x
HIK Hikma PharmaceuticalsUK£18.361.9%
+UK£75.3m
-8.8%PE14.8x
STX Shield TherapeuticsUK£0.08124.0%
+UK£16.3m
112.1%PS2.7x

Latest News